NIFK
MKI67 FHA domain-interacting nucleolar phosphoprotein
Also known as: hNIFK, MK67I_HUMAN, MKI67IP, Nopp34
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BYG3
- Gene
- NIFK
- Ensembl
- ENSG00000155438
- Chromosome
- 2
- Canonical length
- 293 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoli,Nucleoli rim,Mitotic chromosome
OverviewNCBI Gene
This gene encodes a protein that interacts with the forkhead-associated domain of the Ki-67 antigen. The encoded protein may bind RNA and may play a role in mitosis and cell cycle progression. Multiple pseudogenes exist on chromosomes 5, 10, 12, 15, and 19.[provided by RefSeq, Jan 2009]
Canonical amino-acid sequenceUniProt
293 residues, UniProt reviewed canonical sequence.
>Q9BYG3|NIFK
1 MATFSGPAGP ILSLNPQEDV EFQKEVAQVR KRITQRKKQE QLTPGVVYVR HLPNLLDETQ
61 IFSYFSQFGT VTRFRLSRSK RTGNSKGYAF VEFESEDVAK IVAETMNNYL FGERLLECHF
121 MPPEKVHKEL FKDWNIPFKQ PSYPSVKRYN RNRTLTQKLR MEERFKKKER LLRKKLAKKG
181 IDYDFPSLIL QKTESISKTN RQTSTKGQVL RKKKKKVSGT LDTPEKTVDS QGPTPVCTPT
241 FLERRKSQVA ELNDDDKDDE IVFKQPISCV KEEIQETQTP THSRKKRRRS SNQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NIFK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 44 nTPM
- urinary bladder: 41 nTPM
- tonsil: 40 nTPM
- skeletal muscle: 38 nTPM
- breast: 35 nTPM
- ovary: 34 nTPM
Single-cell type
- esophageal basal cells: 173 nCPM
- esophageal suprabasal cells: 144 nCPM
- differentiating spermatogonia: 134 nCPM
- decidual stromal cells: 133 nCPM
- fallopian secretory cells: 127 nCPM
- oocytes: 124 nCPM
Immune cell
- naive CD4 T-cell: 85 nTPM
- MAIT T-cell: 84 nTPM
- NK-cell: 82 nTPM
- naive CD8 T-cell: 80 nTPM
- naive B-cell: 75 nTPM
- total PBMC: 75 nTPM
Brain region
- cerebral cortex: 19 nTPM
- white matter: 18 nTPM
- hippocampal formation: 16 nTPM
- spinal cord: 16 nTPM
- cerebellum: 15 nTPM
- hypothalamus: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.57
- DepMap mean gene effect
- -1.67
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- RNA recognition motif
- MKI67 FHA domain-interacting nucleolar phosphoprotein, FHA Ki67 binding
- FHA Ki67 binding domain of hNIFK
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NIFK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NIFK as an antibody target. Whether an autoantibody or antibody against NIFK could matter depends on whether native NIFK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NIFK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NIFK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...